MetaVia Inc. (NASDAQ: MTVA)
Published June 12, 2026
Views 14.9K | Likes 880 | Comments 28
At a glance
Views
14,996
Likes
880
Comments
28
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
MetaVia Inc. (NASDAQ: MTVA) is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases and is developing DA-1726 for the treatment of obesity, and vanoglipel (DA-1241) for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH). Keynote speakers: Hyung Heon “HH” Kim, Pr…
- Published
- June 12, 2026
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.